Omicron News and Research

RSS
Prior COVID vaccination induces a more robust antibody response to Omicron

Prior COVID vaccination induces a more robust antibody response to Omicron

5 Apr 2022
Framework for genomic surveillance of SARS-CoV-2 Mpro evolution

Framework for genomic surveillance of SARS-CoV-2 Mpro evolution

5 Apr 2022
Study on the efficacy of a BNT162b2 booster dose in the elderly

Study on the efficacy of a BNT162b2 booster dose in the elderly

5 Apr 2022
Air surveillance of SARS-CoV-2 and other respiratory pathogens

Air surveillance of SARS-CoV-2 and other respiratory pathogens

4 Apr 2022
The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

4 Apr 2022
BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

4 Apr 2022
Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

4 Apr 2022
The emergence and limited spread of the Mu SARS-CoV-2 variant

The emergence and limited spread of the Mu SARS-CoV-2 variant

4 Apr 2022
SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

4 Apr 2022
Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

4 Apr 2022
How well does the BNT162b2 vaccine protect children and teens against Omicron?

How well does the BNT162b2 vaccine protect children and teens against Omicron?

4 Apr 2022
Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

2 Apr 2022
Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

1 Apr 2022
Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

1 Apr 2022
Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

1 Apr 2022
NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

31 Mar 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022
Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

31 Mar 2022
Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

31 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback